Literature DB >> 28927076

MicroRNA-154 inhibits the growth and metastasis of gastric cancer cells by directly targeting MTDH.

Wenhui Qiao1, Nong Cao1, Lei Yang1.   

Abstract

MicroRNAs (miRNAs) are a group of non-protein-coding, highly conserved single-stranded RNA molecules. The abnormal expression of miRNAs has been demonstrated to have an important function in the carcinogenesis and progression of gastric cancer. microRNA-154 (miR-154) has been reported to be downregulated in non-small cell lung, colorectal and prostate cancer. However, the expression and roles of miR-154 in gastric cancer remain to be established. The present study measured the expression levels of miR-154 in gastric cancer tissues and cell lines. miR-154 was found to be significantly downregulated in gastric cancer tissues and cell lines. In addition, functional studies indicated that the overexpression of miR-154 inhibited the proliferation, migration and invasion of gastric cancer cells. Using TargetScan, a dual luciferase reporter assay, reverse transcription-quantitative polymerase chain reaction and western blot analysis, metadherin (MTDH) was revealed as a novel miR-154 target. In addition, knocking down MTDH lead to a similar effect as overexpressing-154 in gastric cells. The present findings indicate that miR-154 was downregulated in gastric cancer, and inhibited tumor behaviors of gastric cancer cells partially through the downregulation of MTDH. Therefore, the miR-154/MTDH axis may be a novel therapeutic to treat patients with gastric cancer.

Entities:  

Keywords:  gastric cancer; growth; metadherin; metastasis; microRNA-154

Year:  2017        PMID: 28927076      PMCID: PMC5588056          DOI: 10.3892/ol.2017.6558

Source DB:  PubMed          Journal:  Oncol Lett        ISSN: 1792-1074            Impact factor:   2.967


  36 in total

1.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.

Authors:  K J Livak; T D Schmittgen
Journal:  Methods       Date:  2001-12       Impact factor: 3.608

2.  miR-154 suppresses non-small cell lung cancer growth in vitro and in vivo.

Authors:  Xingyu Lin; Zhiguang Yang; Peng Zhang; Guoguang Shao
Journal:  Oncol Rep       Date:  2015-04-02       Impact factor: 3.906

3.  MicroRNA-140 represses glioma growth and metastasis by directly targeting ADAM9.

Authors:  Xiaogang Liu; Shanjun Wang; Aiqin Yuan; Xunhui Yuan; Bing Liu
Journal:  Oncol Rep       Date:  2016-08-08       Impact factor: 3.906

4.  MiR-145, miR-133a and miR-133b inhibit proliferation, migration, invasion and cell cycle progression via targeting transcription factor Sp1 in gastric cancer.

Authors:  Tianzhu Qiu; Xin Zhou; Jian Wang; Yiping Du; Jun Xu; Zebo Huang; Wei Zhu; Yongqian Shu; Ping Liu
Journal:  FEBS Lett       Date:  2014-03-05       Impact factor: 4.124

5.  Deregulation of MTDH gene expression in gastric cancer.

Authors:  Modjtaba Emadi Baygi; Parvaneh Nikpour
Journal:  Asian Pac J Cancer Prev       Date:  2012

6.  Expression and clinical significance of the microRNA-200 family in gastric cancer.

Authors:  Liang Chang; Fengjie Guo; Bingjie Huo; Yalei Lv; Yudong Wang; Wei Liu
Journal:  Oncol Lett       Date:  2015-03-11       Impact factor: 2.967

Review 7.  Astrocyte elevated gene-1: far more than just a gene regulated in astrocytes.

Authors:  Devanand Sarkar; Luni Emdad; Seok-Geun Lee; Byoung Kwon Yoo; Zao-Zhong Su; Paul B Fisher
Journal:  Cancer Res       Date:  2009-11-10       Impact factor: 12.701

8.  miR-154 suppresses colorectal cancer cell growth and motility by targeting TLR2.

Authors:  Chaoguang Xin; Hao Zhang; Zanchao Liu
Journal:  Mol Cell Biochem       Date:  2013-11-16       Impact factor: 3.396

9.  Expression of AEG-1 mRNA and protein in colorectal cancer patients and colon cancer cell lines.

Authors:  Sebastian Gnosa; Yang-Mei Shen; Chao-Jie Wang; Hong Zhang; Johannes Stratmann; Gunnar Arbman; Xiao-Feng Sun
Journal:  J Transl Med       Date:  2012-05-29       Impact factor: 5.531

10.  A microRNA expression signature of human solid tumors defines cancer gene targets.

Authors:  Stefano Volinia; George A Calin; Chang-Gong Liu; Stefan Ambs; Amelia Cimmino; Fabio Petrocca; Rosa Visone; Marilena Iorio; Claudia Roldo; Manuela Ferracin; Robyn L Prueitt; Nozumu Yanaihara; Giovanni Lanza; Aldo Scarpa; Andrea Vecchione; Massimo Negrini; Curtis C Harris; Carlo M Croce
Journal:  Proc Natl Acad Sci U S A       Date:  2006-02-03       Impact factor: 11.205

View more
  11 in total

1.  Downregulation of miR-588 is associated with tumor progression and unfavorable prognosis in patients with osteosarcoma.

Authors:  Tao Yu; Shuang Liang; Tianhong Ma; Weidong Song
Journal:  Exp Ther Med       Date:  2021-04-08       Impact factor: 2.447

2.  SNHG1 promotes malignant biological behaviors of glioma cells via microRNA-154-5p/miR-376b-3p- FOXP2- KDM5B participating positive feedback loop.

Authors:  Han Li; Yixue Xue; Jun Ma; Lianqi Shao; Di Wang; Jian Zheng; Xiaobai Liu; Chunqing Yang; Qianru He; Xuelei Ruan; Zhen Li; Yunhui Liu
Journal:  J Exp Clin Cancer Res       Date:  2019-02-06

3.  LncRNA MALAT1 promotes neuropathic pain progression through the miR‑154‑5p/AQP9 axis in CCI rat models.

Authors:  Jianping Wu; Chuanguang Wang; Haiyang Ding
Journal:  Mol Med Rep       Date:  2019-11-20       Impact factor: 2.952

4.  miR-30c Impedes Glioblastoma Cell Proliferation and Migration by Targeting SOX9.

Authors:  Shihui Liu; Xiuxiu Li; Sujing Zhuang
Journal:  Oncol Res       Date:  2018-03-01       Impact factor: 5.574

5.  MicroRNA-623 Targets Cyclin D1 to Inhibit Cell Proliferation and Enhance the Chemosensitivity of Cells to 5-Fluorouracil in Gastric Cancer.

Authors:  Lihua Jiang; Wenchuan Yang; Weishi Bian; Hailin Yang; Xia Wu; Yuhua Li; Wen Feng; Xuejian Liu
Journal:  Oncol Res       Date:  2018-03-01       Impact factor: 5.574

6.  Comprehensive analysis of peripheral blood non-coding RNAs identifies a diagnostic panel for fungal infection after transplantation.

Authors:  Anli Yang; Huadi Chen; Jianwei Lin; Ming Han; Xiaopeng Yuan; Tao Zhang; Qingwei Nian; Mengran Peng; Dian Li; Chenglin Wu; Xiaoshun He
Journal:  Bioengineered       Date:  2022-02       Impact factor: 3.269

7.  miR-3189-3p Mimics Enhance the Effects of S100A4 siRNA on the Inhibition of Proliferation and Migration of Gastric Cancer Cells by Targeting CFL2.

Authors:  Yue Bian; Junfu Guo; Linlin Qiao; Xiuju Sun
Journal:  Int J Mol Sci       Date:  2018-01-13       Impact factor: 5.923

8.  Vasodilator-stimulated phosphoprotein (VASP), a novel target of miR-4455, promotes gastric cancer cell proliferation, migration, and invasion, through activating the PI3K/AKT signaling pathway.

Authors:  Haiqun Chen; Gang Dai; Yiting Cai; Qinhao Gong; Wei Wu; Min Gao; Zhewei Fei
Journal:  Cancer Cell Int       Date:  2018-07-09       Impact factor: 5.722

9.  Suppression of nicotinamide phosphoribosyltransferase expression by miR-154 reduces the viability of breast cancer cells and increases their susceptibility to doxorubicin.

Authors:  Zahra Bolandghamat Pour; Mitra Nourbakhsh; Kazem Mousavizadeh; Zahra Madjd; Seyedeh Sara Ghorbanhosseini; Zohreh Abdolvahabi; Zahra Hesari; Samira Ezzati Mobasser
Journal:  BMC Cancer       Date:  2019-11-01       Impact factor: 4.430

10.  miR-154 Influences HNSCC Development and Progression through Regulation of the Epithelial-to-Mesenchymal Transition Process and Could Be Used as a Potential Biomarker.

Authors:  Weronika Tomaszewska; Joanna Kozłowska-Masłoń; Dawid Baranowski; Anna Perkowska; Sandra Szałkowska; Urszula Kazimierczak; Patricia Severino; Katarzyna Lamperska; Tomasz Kolenda
Journal:  Biomedicines       Date:  2021-12-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.